Artelo Biosciences announces annual meeting results; re-elects directors and ratifies auditor

ARTELO BIOSCIENCES, INC.

40.9% of shares represented at Dec 20, 2024 annual meeting (1,319,986 of 3,227,700 outstanding).
Directors Steven Kelly and R. Martin Emanuele re-elected to Class I board seats until 2027.
Ratification of Malone Bailey LLP as independent auditor for FY ending Dec 31, 2024 (1,258,378 for, 57,083 against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.